The purpose of this study is to conduct a randomized trial to evaluate a proactive, opt-out model of provider contact to deliver smoking cessation support for people living with HIV compared to standard care support delivered through traditional clinic pathways. Investigators will also evaluate implementation outcomes to identify barriers and facilitators towards future implementation. Investigators hope to define best practices and optimize the delivery of smoking cessation interventions for people living with HIV.
This hybrid effectiveness-implementation trial presents on opportunity to optimize tobacco treatment delivery for people living with HIV (PLWH), and identify barriers and facilitators towards future implementation. We are proposing a comparison of Treatment As Usual (TAU; reactive, opt-in tobacco treatment using standard clinical pathways) vs Proactive Outreach with Medication Opt-out for Tobacco Treatment Engagement (PrOMOTE). Participants will be randomized in a 1:1 allocation. The primary aim is to compare rates of cessation and quit attempts at the Week 12 follow-up between participants who received TAU versus PrOMOTE. As a secondary aim we will characterize key determinants of PrOMOTE reach, implementation fidelity, adherence, and acceptability. We hypothesize that the PrOMOTE intervention will increase cessation rates and number of quit attempts, and that it will result in greater reach and pharmacotherapy delivery compared to TAU. Key determinants of PrOMOTE implementation outcomes will also be characterized. An exploratory assessment of CD4 cell count and HIV viral load, in addition to durability of smoking cessation outcomes, will also be assessed. By optimizing the delivery of effective tobacco treatments for PLWH, we hope to increase the number of people receiving tobacco treatment, increase tobacco cessation rates, and reduce the risk of morbidity and mortality from smoking-related causes.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
231
This is an opt-out, proactive approach to tobacco treatment by a clinical pharmacy specialist. The pharmacist will call patients and offer an individualized pharmacotherapy prescription. The patient must opt-out for it not to be sent to their pharmacy. The patient will also receive brief motivational interviewing and behavioral counseling from the pharmacist.
Medical University of South Carolina
Charleston, South Carolina, United States
RECRUITINGTobacco use abstinence
Self-reported and confirmed by breath carbon monoxide test
Time frame: 7 days
Reach
Percentage of current smokers engaged in an intervention
Time frame: 24 weeks (study completion)
Fidelity of intervention
The extent to which an intervention is implemented as intended. This will be collected via interviews with patients and providers.
Time frame: 24 weeks (study completion)
Fidelity of intervention
The extent to which an intervention is implemented as intended. This will be collected via surveys.
Time frame: 24 weeks (study completion)
Perceived barriers to the outcomes
Using the implementation tracking checklist, provider perceptions of barriers faced in completion of intervention steps will be monitored. These will be collected via interviews with patients.
Time frame: 24 weeks (study completion)
Perceived barriers to the outcomes
Using the implementation tracking checklist, provider perceptions of barriers faced in completion of intervention steps will be monitored. These will be collected via interviews with providers.
Time frame: 24 weeks (study completion)
Acceptability of intervention
The perception among stakeholders that the treatment is agreeable or satisfactory. This will be collected via interviews with patients and providers.
Time frame: 24 weeks (study completion)
Acceptability of intervention
The perception among stakeholders that the treatment is agreeable or satisfactory. This will be collected via surveys.
Time frame: 24 weeks (study completion)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.